Structure of BthA-I complexed with p-bromophenacyl bromide: possible correlations with lack of pharmacological activity

dc.contributor.authorMagro, A. J.
dc.contributor.authorTakeda, AAS
dc.contributor.authorSoares, A. M.
dc.contributor.authorFontes, MRM
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2014-05-20T13:49:21Z
dc.date.available2014-05-20T13:49:21Z
dc.date.issued2005-12-01
dc.description.abstractThe crystal structure of an acidic phospholipase A(2) isolated from Bothrops jararacussu venom (BthA-I) chemically modified with p-bromophenacyl bromide (BPB) has been determined at 1.85 angstrom resolution. The catalytic, platelet-aggregation inhibition, anticoagulant and hypotensive activities of BthA-I are abolished by ligand binding. Electron-density maps permitted unambiguous identification of inhibitor covalently bound to His48 in the substrate-binding cleft. The BthA-I-BPB complex contains three structural regions that are modified after inhibitor binding: the Ca2+-binding loop, ss-wing and C-terminal regions. Comparison of BthA-I-BPB with two other BPB-inhibited PLA(2) structures suggests that in the absence of Na+ ions at the Ca2+- binding loop, this loop and other regions of the PLA(2)s undergo structural changes. The BthA-I-BPB structure reveals a novel oligomeric conformation. This conformation is more energetically and conformationally stable than the native structure and the abolition of pharmacological activities by the ligand may be related to the oligomeric structural changes. A residue of the `pancreatic' loop (Lys69), which is usually attributed as providing the anticoagulant effect, is in the dimeric interface of BthA-I-BPB, leading to a new hypothesis regarding the abolition of this activity by BPB.en
dc.description.affiliationUniv Estadual Paulista Julio Mesquita Filho, Inst Biociencias, Dept Fis & Biofis, BR-18618000 Botucatu, SP, Brazil
dc.description.affiliationUSP, Dept Anal Clin Toxicol & Bromatol, FCFRP, BR-14040903 Ribeirao Preto, SP, Brazil
dc.description.affiliationUnespUniv Estadual Paulista Julio Mesquita Filho, Inst Biociencias, Dept Fis & Biofis, BR-18618000 Botucatu, SP, Brazil
dc.format.extent1670-1677
dc.identifierhttp://dx.doi.org/10.1107/S0907444905029598
dc.identifier.citationActa Crystallographica Section D-biological Crystallography. Oxford: Blackwell Publishing, v. 61, p. 1670-1677, 2005.
dc.identifier.doi10.1107/S0907444905029598
dc.identifier.issn0907-4449
dc.identifier.urihttp://hdl.handle.net/11449/17581
dc.identifier.wosWOS:000233392900015
dc.language.isoeng
dc.publisherBlackwell Publishing
dc.relation.ispartofActa Crystallographica Section D: Biological Crystallography
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.titleStructure of BthA-I complexed with p-bromophenacyl bromide: possible correlations with lack of pharmacological activityen
dc.typeArtigo
dcterms.licensehttp://olabout.wiley.com/WileyCDA/Section/id-406071.html
dcterms.rightsHolderBlackwell Publishing
unesp.author.lattes0059017255172730[1]
unesp.author.orcid0000-0002-4634-6221[4]
unesp.author.orcid0000-0001-5000-6652[2]
unesp.author.orcid0000-0002-4253-6992[1]
unesp.campusUniversidade Estadual Paulista (Unesp), Instituto de Biociências, Botucatupt

Arquivos

Licença do Pacote
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: